Изучение влияния различных диетических рационов на показатели цитокинового статуса и апоптоза у больных сахарным диабетом 2 типа
Скачать 0.92 Mb.
|
A low–fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes / N.D. Barnard, L. Gloede, J. Cohen, D.J. Jenkins, et al. // J Am Diet Assoc. – 2009. – V.109. – №2. – P.263–272. A novel anti–inflammatory role for spleen–derived interleukin–10 in obesity–induced inflammation in white adipose tissue and liver / K. Gotoh, M. Inoue, T. Masaki, S. Chiba, et al. // Diabetes. – 2012. – V.61. – N8. – P.1994–2003. A randomized clinical trial with two doses of an enteral diabetes–specific suplements in elderly patients with diabetes mellitus type 2 / D.A. De Luis, O. Izaola, B. De la Fuente, M.C. Terroba, et al. // Eur Rev Med Pharmacol Sci. – 2013. – V.17. – N12. – P.1626–30. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes / L.R. Saslow, S. Kim, J.J. Daubenmier, J.T. Moskowitz, et al. // PLoS One. – 2014. – V.9. – N4:e91027. A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes / G.N. Thomas, C.Q. Jiang, S. Taheri, Z.H. Xiao, et al. // Curr Diabetes Rev. – 2010. – V.6. – N6. – P.378–87. Abbott–97–004 Study Cooperative Group. Glycemic and lipid control in hospitalized type 2 diabetic patients: evluationof 2 enteral nutrition formulas / M. Leon Sanz, P. Garcia Luna, A. Sanz Paris, C. Gomez Candela, et al. // J Parenter Enteral Nutr. – 2005. – N29. – P.21–29. Abdul–Aziz K.K. Targeting tumor necrosis factor alpha (TNF–α) in diabetic rats could approve avenues for an efficient strategy for diabetic therapy / K.K. Abdul–Aziz, M.J. Tuorkey // Diabetes Metab Syndr. – 2012. – V.6. – N2. – P.77–84. Acheson K.J. Carbohydrate for weight and metabolic control: where do we stand? / K.J. Acheson // Nutrition. – 2010. – V.26. – N2. – P.141–145. Acute effects of monounsaturated fatty acids with and without omega–3 fatty acids on vascular reactivity in individuals with type 2 diabetes / S.G. West, K.D. Hecker, V.A. Mustad, S. Nicholson, et al. // Diabetologia. – 2005. – V.48. – P. 113–122. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease / K.H. Cheng, C.S. Chu, K.T. Lee, et al. // Int J Obes (Lond). – 2008. – N32. – P.268–274. Administration of a new diabetes–specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients / A. Ceriello, M. Lansink, C.H. Rouws, van K.M. Laere, et al. // Diabetes Res Clin Pract. – 2009. – V.84. – N3. – P.259–66. Advanced glycation end product precursors impair epidermal growth factor receptor signaling / M. Portero–Otín, R. Pamplona, M.J. Bellmunt, M.C. Ruiz, et al. // Diabetes. – 2002. – V.51. – N5. – P.1535–1542. Ajala O. Systematic review and meta–analysis of different dietary approaches to the management of type 2 diabetes / O. Ajala, P. English, J. Pinkney // Am J Clin Nutr. – 2013. –V.97. – N3. – P.505–516. American Diabetes Association. Nutrition recommendations and interventions for diabetes // Diabetes Care. – 2010. – N30. – P.48–65. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors;American Society for Parenteral and Enteral Nutrition. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia / M.M. McMahon, E. Nystrom, C. Braunschweig, J. Miles, et al. // J Parenter Enteral Nutr. – 2013. – V.37. – N1. – P.23–36. Ashkenazi A. Death receptors: signaling and modulation / A. Ashkenazi, V. Dixit // Science. – 2008. – V.281. – P.1305–1308. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies / A.E. Buyken, J. Goletzke, G. Joslowski, A. Felbick, et al. // Am J Clin Nutr. – 2014. – V.99. – N4. – P.813–33. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex–related analysis / P. Di Bonito, E. Sanguigno, T. Di Fraia, C. Forziato, et al. // Metabolism. – 2009. – V.58. – N3. – P.368–72. Association of high carbohydrate versus high fat diet with glycated hemoglobin in high calorie consuming type 2 diabetics / Z. Shadman, M. Khoshniat, N. Poorsoltan, M. Akhoundan, et al. // J Diabetes Metab Disord. – 2013. – N12. – P.27. Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes / S.K. Paine, A. Basu, L.K. Mondal, A. Sen, et al. // Mol Vis. – 2012. – V.18. – P.2749–57. Associations of small dense low–density lipoprotein and adiponectin with complications of type 2 diabetes / A. Esteghamati, S. Asnafi, M. Eslamian, S. Noshad, et al. // Endocr Res. – 2014. – P.1–6. Astrup A. Atkins and other low–carbohydrate diets: hoax or an effective tool for weight loss? / A. Astrup, T. Meinert Larsen, A. Harper // Lancet. – 2004. – V.364 – N9437 – P.897–899. Bakhai A. Adipokines––targeting a root cause of cardiometabolic risk / A. Bakhai // QJM. – 2008. – V.101. – N10. – P.767–76. Balistreri C.R. The role of adipose tissue and adipokines in obesity–related inflammatory diseases / C.R. Balistreri, C. Caruso, G. Candore // Mediators Inflamm. – 2010: www.hindawi.com/journals/mi/2010/802078/. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity / Y. Miyashita, N. Koide, M. Ohtsuka, H. Ozaki, et al. // Diabetes Res Clin Pract. – 2004. – V.65. – N3. – P.235–41. Beneficial effects of a diabetes specific formula on insulin sensitivity and free fatty acid in patients with type 2 diabetes mellitus / Y.X. Li, J.B. Zeng, K. Yu, Q. Sun, et al. // ChinMedJ. – 2008. – V.121. – N8. – P.691–5. Bergmann K. Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? / K. Bergmann, G. Sypniewska // Clin Chem Lab Med. – 2013. – V.51. – N1. – P.177–185. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II / P.H. Black // Med Hypotheses. – 2006. – V.67. – N4. – P.879–891. Blood glucose and insulin responses to two hypocaloric enteral formulas in patients with diabetes mellitus type 2 / D.A. De Luis, O. Izaola, B. De la Fuente, K. Araújo // Nutr Hosp. – 2013. – V.28. – N3. – P.600–96. Böni–Schnetzler M. How biologics targeting the IL–1 system are being considered for the treatment of type 2 diabetes / M. Böni–Schnetzler, M.Y. Donath // Br J Clin Pharmacol. – 2013. – V.76. – N2. – P.263–268. Brown S.B. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes / S.B. Brown, J. Savil // J Immunol. – 2009. – V.162. – P.480–485. Brownlee M. Biochemistry and molecular cell biology of diabetic complications / M. Brownlee // Nature. – 2001. –V.73/4J4. – P.873–20. Carbohydrate–restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and improving blood lipids / N.D. Luscombe–Marsh, M. Noakes, G.A. Wittert, J.B. Keogh, et al. // Am J Clin Nutr. – 2005. – V.81. – N4. – P.762–72. Caspase–9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function / M.J. White, S.M. Schoenwaelder, E.C. Josefsson, K.E. Jarman, et al. // Blood. – 2012. – V.119. – N18. – P.4283–90. Castañeda–González L.M. Effects of low carbohydrate diets on weight and glycemic control among type 2 diabetesindividuals: a systemic review of RCT greater than 12 weeks / L.M. Castañeda–González, G.M. Bacardí, C.A. Jiménez // Nutr Hosp. – 2011. – V.26. – N6. – P.1270–6. Cellular hypoxia and adipose tissue dysfunction in obesity / I.S. Wood, de F.P. Heredia, B. Wang, P. Trayhurn // Proc Nutr Soc. – 2009. – V.68. – N4. – P.370–7. Circulating levels of insulin–like growth factor–II/mannose–6–phosphate receptor in obesity and type 2 diabetes / N. Jeyaratnaganthan, K. Højlund, J.P. Kroustrup, J.F. Larsen, et al. // Growth Horm IGF Res. – 2010. – V.20. – N3. – P.185–91. Circulating levels of TNF–α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study / N.C. Olson, P.W. Callas, A.J. Hanley, A. Festa, et al. // J Clin Endocrinol Metab. – 2012. – V.97. – N3. – P.1032–40. Colagiuri S. Diabesity: therapeutic options / S. Colagiuri // Diabetes Obes Metab. – 2010. – V.12. – N6. – P.463–473. Colwell J. A. Type 2 Diabetes, Pre–Diabetes, and the Metabolic Syndrome / J. A. Colwell // JAMA. – 2011. – V.306. – N2. – P.215. Comparison of 3 ad libitum diets for weight–loss maintenance, risk of cardiovascular disease, and diabetes: a 6–mo randomized, controlled trial / A. Due, T.M. Larsen, H. Mu, K. Hermansen, et al. // Am J Clin Nutr. – 2008. – V.88. – N5. – P.1232–41. Comparison of a high–protein disease–specific enteral formula with a high–protein enteral formula in hyperglycemic critically ill patients / A. Mesejo, J.A. Acosta, C. Ortega, J. Vila, et al. // Clin Nutr. – 2003. – V.22. – N3. – P.295–305. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states / L. Berglund, M. Lefevre, H.N. Ginsberg, P.M. Kris–Etherton, et al. // Am J Clin Nutr. – 2007. – N 86. – P.1611–1620. Comparison of the effects on insulin resistance and glucose tolerance of 6–mo high–monounsaturated–fat, low–fat, and control diets / A. Due, T.M. Larsen, K. Hermansen, S. Stender, et al. // Am J Clin Nutr. – 2008. – V.87. – N4. – P.855–62. Coppack S.W. Pro–inflammatory cytokines and adipose tissue / S.W. Coppack // Proc Nutr Soc. – 2001. – V.60. – N3. – P.349–56. De Heredia F.P. Obesity, inflammation and the immune system / F.P. De Heredia, S. Gómez–Martínez, A. Marcos // Proc Nutr Soc. – 2012. – V.71. – N2. – P.332–8. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications / J.J. Corrales, M. Almeida, R.M. Burgo, et al. // J Diabetes Complications. – 2007. – N 21(1). – Р.41–49. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice / S. Wueest, R.A. Rapold, D.M. Schumann, J.M. Rytka, et al. // J Clin Invest. – 2010. – V.120. – N1. – P.191–202. Dietary carbohydrates and intestinal lipoprotein production / C. Morgantini, C. Xiao, S. Dash, G.F. Lewis // Curr Opin Clin Nutr Metab Care. – 2014. 17(4). - P. 355-9. Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study / C. Cruz–Teno, P. Pérez–Martínez, J. Delgado–Lista, E.M. Yubero–Serrano, et al. // Mol Nutr Food Res. – 2012. – V.56. – N6. – P.854–65. Dinarello C.A. Role of IL–1beta in type 2 diabetes / C.A. Dinarello, M.Y. Donath, T. Mandrup–Poulsen // Curr Opin Endocrinol Diabetes Obes. – 2010. – V.17. – N4. – P.314–21. Dulloo A.G. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview / A.G. Dulloo, J.P. Montani // Obes Rev. – 2012. – V.13. – N2. – P.1–5. Echouffo–Tcheugui J.B. Preventing diabetes mellitus in developing countries / J.B. Echouffo–Tcheugui, S. Dagogo–Jack // Nature Reviews Endocrinology. – 2012. – V.8. – P.557–562. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus / K.R. Sargrad, C. Homko, M. Mozzoli, G. Boden // J Am Diet Assoc. – 2005. – V.105. – N4. – P.573–80. Effect of TGF–β on ocular surface epithelial cells / M.J. Benito, V. Calder, R.M. Corrales, C. García–Vázquez, et al. // Exp Eye Res. – 2013. – V.107. – P.88–100. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial / M. Juanola–Falgarona, J. Salas–Salvadó, N. Ibarrola–Jurado, A. Rabassa–Soler, et al. // Am J Clin Nutr. – 2014. - V.100. - N (1). – P. 27-35. Effects of a diabetes–specific enteral nutrition on nutritional and immune status of diabetic, obese, and endotoxemic rats: interest of a graded arginine supply / C. Breuillard, S. Darquy, E. Curis, N. Neveux, et al. // Crit Care Med. – 2012. – V.40. – N 8. – P. 2423–30. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor–alpha in rats with sucrose–induced metabolic syndrome / A.A. Aguilera, G.H. Diaz, M.L. Barcelata, R.M. Ros // J Nutr Biochem. – 2004. – N15. – P.350–357. Effects of high–monounsaturated fatty acid enteral formula versus high–carbohydrate enteralformula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients / J. Yokoyama, Y. Someya, R. Yoshihara, H. Ishii // J Int Med Res. – 2008. – V.36. – N1. – P.137–46. El–Sayed M.J.S. From obesity genetics to the future of personalized obesity therapy / M.J.S. El–Sayed, P. Froguel // Nature Reviews Endocrinology. – 2013. – V.9. – N7. – P.402–13. Enerbäck S. Brown adipose tissue in humans / S. Enerbäck // Int J Obes (Lond). – 2010. – V.34. – N1. – P.43–46. Enteral nutritional support and use of diabetes–specific formulas for patients with diabetes / M. Elia, A. Ceriello, H. Laube, et al. // Diabetes Care. – 2005. – V.28. – P.2267–2279. Evidence–based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications / M.J. Franz, J.P. Bantle, C.A. Beebe et al. // Diabetes Care. – 2002. – V.25. – P.148–198. Ezaki O. The optimal dietary fat to carbohydrate ratio to prevent obesity in the Japanese population: a review of the epidemiological, physiological and molecular evidence / O. Ezaki // J Nutr Sci Vitaminol (Tokyo). – 2011. – V.57. – N6. – P.383–93. Fain J.N. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review / J.N. Fain J.N. // Mediators Inflamm. – 2010:513948. Fernández–Real J.M. Innate immunity, insulin resistance and type 2 diabetes / J.M. Fernández–Real, J.C. Pickup // Trends Endocrinol Metab. – 2008. – V.19. – N1. – P.10–6. Ferrante A.W. Obesity–induced inflammation: a metabolic dialogue in the language of inflammation / A.W. Ferrante // Journal of Internal Medicine. – 2007. – V.262. – N4. – P.408–414. Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration / Y. Yun, J.E. Won, E. Jeon, S. Lee, et al. // Journal of Tissue Engineering. – 2010. – N 1. – 218142. Fibroblasts as novel therapeutic targets in chronic inflammation / S.J. Flavell, T.Z. Hou, S. Lax, A.D. Filer, et al. // British Journal of Pharmacology. – 2008. – V.153. – N1. – P.241–246. Finnish Diabetes Prevention Study Group. Anti–inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study / C. Herder, M. Peltonen, W. Koenig, K. Sütfels, et al. // Diabetologia. – 2009. – V.52. – N3. – P.433–42. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity / C. Pop, A. Oberst, M. Drag, B.J. Van Raam, et al. // Biochem J. – 2011. – V.433. – N3. – P.447–57. Franz M.J. Evidence–based diabetes nutrition therapy recommendations are effective: the key is individualization / M.J. Franz, J.L. Boucher, A.B. Evert // Diabetes Metab Syndr Obes. – 2014. – V.7. – P.65–72. Frühbeck G. The adipose tissue as a source of vasoactive factors / G. Frühbeck // Curr Med Chem Cardiovasc Hematol Agents. – 2004. – V.2. – N3. – P.197–208. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta–analysis / P. Carter, L.J. Gray, J. Troughton, K. Khunti, et al. // BMJ. – 2010. – V.341. – P.4229. Galic S. Adipose tissue as an endocrine organ / S. Galic, J.S. Oakhill, G.R. Steinberg // Mol Cell Endocrinol. – 2010. – V.316. – N2. – P.129–39. Georgoulis M. Mediterranean diet and diabetes: prevention and treatment / M. Georgoulis, M.D. Kontogianni, N. Yiannakouris // Nutrients. – 2014. – V.6. – N4. – P.1406–23. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 / S. Wild, G. Roglic, A. Green, R. Sicree, et al. // Diabetes Care. – 2004. – V.27. – N5. – P.1047–1053. Glycemic control in patientswith type 2 diabetes mellitus with type 2 diabetes mellitus with a specific disease enteral formula: stage II of a randomized, controlled multicenter trial / M. Pohl, P. Mayr, M. Mertl–Roetzer, F. Lauster, et al. // J Parenter Enteral Nutr. – 2009. – N33. – P.37–49. Goldfine A.B. Therapeutic approaches to target inflammation in type 2 diabetes / A.B. Goldfine, V. Fonseca, S.E. Shoelson // Clin Chem. – 2011. – V.57. – N2. – P.162–7. Green D.R. Apoptotic pathways: ten minutes to dead / D.R. Green // Cell. – 2005. – V.121. – P.671–674. Gunawardana S.C. Reversal of type 1 diabetes in mice by brown adipose tissue transplant / S.C. Gunawardana, D.W. Piston // Diabetes. – 2012. – V.61. – N3. – P.674–682. Heilbronn L.K. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity / L.K. Heilbronn, L.V. Campbell // Curr Pharm Des. –2008. – V.14. – N12. – P.1225–30. Hemoglobin A1c as a predictor of incident diabetes / P. Cheng, B. Neugaard., P. Foulis, P.R. Conlin // Diabetes Care. – 2011. – V.34. – N3. – P.610–5. High saturated–fat and low–fibre intake: a comparative analysis of nutrient intake in individuals with and without type 2 diabetes / C. Breen, M. Ryan, B. McNulty, M.J. Gibney, et al. // Nutr Diabetes. – 2014. –V.4. – N2. – P.104. Hjartåker A. Obesity and diabetes epidemics: cancer repercussions / A. Hjartåker, H. Langseth, E. Weiderpass // Adv Exp Med Biol. – 2008. – N630. – P.72–93. Hofman Z. The Glycemic Index of standard and diabetes–specific enteral formulas / Z. Hofman, J. De Van Drunen, H. Kuipers // Asia Pac J Clin Nutr. – 2006. – V.15. – N3. – P.412–7. Hotamisligil G.S. Inflammation and metabolic disorders / G.S. Hotamisligil // Nature. – 2006. – V.444. – N7121. – P.860–867. IDF Diabetes Atlas, 5th ed., 2011. Implication of inflammatory signaling pathways in obesity–induced insulin resistance / J. Tanti, F. Ceppo, J. Jager, F. Berthou // Front Endocrinol (Lausanne). – 2013. – V.3. – P.181. Inflamed adipose tissue, insulin resistance and vascular injury. / C.X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, et al. // Diabetes/Metabolism Research and Reviews. – 2008. – V.24. – N8. – P.595–603. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes / N. Esser, S. Legrand–Poels, J. Piette, A.J. Scheen, et al. // Diabetes Res Clin Pract. – 2014. – V.105. - N2. – P.141-50. Inflammation, adiponectin, obesity and cardiovascular risk / H. Mangge, G. Almer, M. Truschnig–Wilders, A. Schmidt, et al. // Current Medicinal Chemistry. – 2010. – V.17. – N36. – P.4511–4520. Inflammatory Process in Type 2 Diabetes / K. Alexandraki, C. Piperi, C. Kalofoutis, J. Singh, et al. // Annals of the New York Academy of Sciences. – 2006. – V.1084. – N1. – P.89–117. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2diabetes: a meta–analysis / S. Kodama, K. Saito, S. Tanaka, M. Maki, et al. // Diabetes Care. – 2009. – V.32. – N5. – P.959–65. Insulin–like growth factor binding protein–2 (IGFBP–2) is a marker for the metabolic syndrome / A.H. Heald, K. Kaushal, K.W. Siddals, A.S. Rudenski, et al. // Exp Clin Endocrinol Diabetes. – 2006. – V.114. – N7. – P.371–6. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes / A. Patel., S. MacMahon, J. Chalmers et al. [ADVANCE Collaborative Group] // N. Engl. J. Med. – 2008. – V.358. – P. 2560–2572. Interleukin–targeted therapy for metabolic syndrome and type 2 diabetes / K. Maedler, G. Dharmadhikari, D.M. Schumann, J. Storling // Handb Exp Pharmacol. – 2011. – N203. – P.257–78. International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update / A. Ceriello, J. Davidson, M. Hanefeld, L. Leiter, et al. // Nutr Metab Cardiovasc Dis. – 2006. – N16. – P.453–456. Japanese Elderly Diabetes Intervention Trial Study Group. Effects of total and green vegetable intakes on glycated hemoglobin A1c and triglycerides in elderly patients with type 2 diabetes mellitus: the Japanese Elderly Intervention Trial / K. Takahashi, C. Kamada, H. Yoshimura, R. Okumura, et al. // Geriatr Gerontol Int. – 2012. – V.12. – Suppl 1. – P.50–8. Kaur B. Micronutrient status in type 2 diabetes: a review / B. Kaur, J. Henry // Adv Food Nutr Res. – 2014. – N71. – P.55–100. Kazemi Arababadi M. Interleukin–4 gene polymorphisms in type 2 diabetic patients with nephropathy / M. Kazemi Arababadi // Iran J Kidney Dis. – 2010. – V.4. – N4. – P.302–6. Keeley E.C. Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis / E.C. Keeley, B. Mehrad, R.M. Strieter // The international journal of biochemistry & cell biology. – 2010. – V.42. – N4. – P. 535–542. Keller U. Dietary proteins in obesity and in diabetes / U. Keller // Int J Vitam Nutr Res. – 2011. – N81 (2–3). – P.125–33. Khazrai Y.M. Effect of diet on type 2 diabetes mellitus: a review / Y.M. Khazrai, G. Defeudis, P. Pozzilli // Diabetes Metab Res Rev. – 2014. – V.30. – Nl. – P.24–33. King G.L.The role of inflammatory cytokines in diabetes and its complications / G.L. King // J Periodontol. – 2008. – V.79. – N8. – P.1527–34. Kolluru G.K. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing / G.K. Kolluru, S.C. Bir, C.G. Kevil // Int J Vasc Med. – 2012. – 918267. Kurokawa M. Caspase and kinases in a death grip / M. Kurokawa, S. Kornbluth // Cell. – 2009. – V.4. – N138 (5). – P.838–854. Lam D.W. The worldwide diabetes epidemic / D.W. Lam, D. LeRoith // Curr Opin Endocrinol Diabetes Obes. – 2012. – V.19. – N2. – P.93–6. Lane P.H. Streptozocin diabetes elevates all isoforms of TGF–beta in the rat kidney / P.H. Lane, D.M. Snelling, W.J. Langer // Int J Exp Diabetes Res. – 2001. – V.2. – N1. – P.55–62. Le Roith D. Dyslipidemia and glucose dysregulation in overweight and obese patients / D. Le Roith // Clin Cornerstone. – 2007. – V.8. – P.38–52. Long–term effect of dietary fibre intake on glycosylated haemoglobin A1c level and glycaemic control status among Chinese patients with type 2 diabetes mellitus / L. Yang., L. Shu, J. Jiang, H. Qiu, et al. // Public Health Nutr. – 2013. – P.1–7. Каталог: files files -> Вопросы сертификационного экзамена для врачей по специальности «лфк и спортивная медицина» files -> Рабочая программа составлена в соответствии с Требованиями к содержанию дополнительных профессиональных образовательных программ files -> Рабочая программа дисциплины Лечебная физическая культура и массаж Направление подготовки 050100 Педагогическое образование files -> Лечебная физкультура files -> К рабочей программе дисциплины «Лечебная физкультура и спортивная медицина» files -> Рабочая программа учебной дисциплины «медицинская реабилитация» цикла Медицинская реабилитация для специальности 310501 «Лечебное дело» по специализации 310501 «Лечебное дело» files -> Лекции (час) Семинары (час) Самост работа Всего баллов Модуль 1 files -> Влияние мобильного телефона на здоровье человека Скачать 0.92 Mb. Поделитесь с Вашими друзьями:
|